Novo Nordisk (NVO) faced a setback with an earnings miss, causing a 4% drop in its stock price.…
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have revolutionized the treatment of obesity and diabetes. These drugs…
Novo Nordisk's Multi-Pronged Strategy to Regain Market Share in Obesity Drug Market The pharmaceutical firm Novo Nordisk is…
Fatty liver disease can lead to cirrhosis and cancer3dMediSphere/Shutterstock A breakthrough discovery has shown that a well-known drug…
The phenomenon of changes in food preferences and tastes among users of weight-loss medications like Wegovy, semaglutide, and…
Can weight-loss drugs ditch the needles? Can weight-loss drugs ditch the needles? Aleksandr Zubkov/Getty Images A daily pill…
Novo Nordisk has announced that it will be offering its obesity drug Wegovy directly to patients at a…
Medicare officials have recently announced their plans to negotiate the prices of two popular drugs, Ozempic and Wegovy,…
Novo Nordisk's popular diabetes and obesity medications, Ozempic and Wegovy, have been listed on the Food and Drug…
State Medicaid programs have historically not covered the new class of weight loss drugs for obesity, but recent…
Novo Nordisk, the maker of Ozempic, has announced exciting new data regarding their upcoming weight loss pill. This…
Related feature: STAT’s Obesity Drug Tracker, updated and with a new feature that allows the entire dataset to…
Sign in to your account